New-onset type 1 diabetes mellitus triggered by SARS-CoV-2 infection in a patient with Hashimoto thyroiditis: a case report

New-onset type 1 diabetes mellitus triggered by SARS-CoV-2 infection in a patient with Hashimoto thyroiditis: a case report

New onset type 1 diabetes mellitus is an uncommon but possible complication triggered by SARSCoV- 2 infection. Metabolic inflammation supported by cytokine storm leading to pancreatic beta cells destruction is the most probable link between COVID-19 and diabetes. Here, we describe the case of a 51-...

Full description

Bibliographic Details
Main Authors:	Elena Schipani, Andrea Cozzi, Giuseppe Salvatore Murgida, Valentina Francolini, Eleonora Sisti, Stefania Di Martino, Francesca Dainelli, Rosa Vecchio, Elisa Grifoni, Luca Masotti
Format:	Article
Language:	English
Published:	PAGEPress Publications 2021-01-01
Series:	Italian Journal of Medicine
Subjects:	Diabetes SARS-CoV-2 COVID-19 hyperglycemia glutamic acid decarboxylase-65 autoantibodies.
Online Access:	https://www.italjmed.org/index.php/ijm/article/view/1387

Similar Items

The Role of GAD65 Autoantibody in Diabetes Mellitus and their First-Degree Relatives and Comparison with Healthy Persons
by: M Nakhjavani, et al.
Published: (2001-06-01)

Prevalence of Beta-Cell, Thyroid and Celiac Autoimmunity in North Indian Children with Recent Onset Type 1 Diabetes (T1D)
by: Devi Dayal, et al.
Published: (2015-03-01)

Glutamic Acid Decarboxylase Autoantibodies-Related Encephalitis
by: J Gordon Millichap
Published: (2011-09-01)

Characterization of the humoral immune response to the beta-cell antigens insulin and glutamic acid decarboxylase in preclinical and clinical type 1 diabetes
by: Ronkainen, M. (Matti)
Published: (2005)

Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
by: Young Hwa Kong, et al.
Published: (2013-06-01)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
by: Tao-Ran Li, et al.
Published: (2020-03-01)

Geographic location determines beta‐cell autoimmunity among adult Ghanaians: Findings from the RODAM study
by: Christiane S. Hampe, et al.
Published: (2020-09-01)

AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
by: N. V. Piven, et al.
Published: (2014-07-01)

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function
by: Yuxiao Zhu, et al.
Published: (2020-04-01)

Typical case of LADA
by: A A Krivko, et al.
Published: (2009-03-01)

Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital
by: Rumei Li, et al.
Published: (2018-05-01)

UNRAVELING THE ARCHITECTURE OF THE DORSAL RAPHE SYNAPTIC NEUROPIL USING HIGH-RESOLUTION NEUROANATOMY
by: Mariano eSoiza-Reilly, et al.
Published: (2014-08-01)

Circulating anti‐glutamic acid decarboxylase‐65 antibody titers are positively associated with the capacity of insulin secretion in acute‐onset type 1 diabetes with short duration in a Japanese population
by: So Yamamura, et al.
Published: (2019-11-01)

Laminar Distribution of Subsets of GABAergic Axon Terminals in Human Prefrontal Cortex
by: Kenneth N. Fish, et al.
Published: (2018-02-01)

A Novel Approach of Identifying Immunodominant Self and Viral Antigen Cross-Reactive T Cells and Defining the Epitopes They Recognize
by: Junbao Yang, et al.
Published: (2018-12-01)

IMMUNOLOGIC PREVENTION OF IDDM BY ORAL ADMINISTRATION OF GLUTAMIC ACID DECARBOXYLASE
by: L. Yazdchi Mari, et al.
Published: (1999-09-01)

IMMUNOLOGIC PREVENTION OF IDDM BY ORAL ADMINISTRATION OF GLUTAMIC ACID DECARBOXYLASE
by: L. Yazdchi Mari, et al.
Published: (1999-12-01)

Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series
by: Changhong Ren, et al.
Published: (2021-04-01)

Effects of electroacupuncture on pain sensation in a rat model of hyperalgesia with nicotine dependence
by: Shu-Ju Wang, et al.
Published: (2022-01-01)

Islet Autoantibodies in the Patients with Sjogren’s Syndrome and Thyroid Disease and Risk of Progression to Latent Autoimmune Diabetes in Adults: A Case Series
by: Wen S, et al.
Published: (2021-03-01)

Serum brain-derived neurotrophic factor and neurocognitive function in children with type 1 diabetes
by: Hui-Ju Chen, et al.
Published: (2021-01-01)

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice
by: David P. Funda, et al.
Published: (2018-02-01)

Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies
by: Maëlle Dade, et al.
Published: (2021-01-01)

Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient
by: Juliana Gomez, et al.
Published: (2019-01-01)

Mechanisms of extreme acid resistance in new and atypical Brucella strains
by: Freddi, Luca
Published: (2017)

The effect of sodium thiopental as a GABA mimetic drug in neonatal period on expression of GAD65 and GAD67 genes in hippocampus of newborn and adult male rats
by: Masoud Naseri, et al.
Published: (2017-09-01)

Neurological Syndromes Associated with Anti-GAD Antibodies
by: Maëlle Dade, et al.
Published: (2020-05-01)

Glutamic Acid Decarboxylase Concentration Changes in Response to Stress and Altered Availability of Glutamic Acid in Rabbit (<i>Oryctolagus cuniculus</i>) Brain Limbic Structures
by: Izabela Szpręgiel, et al.
Published: (2021-02-01)

Partial Cloning and Nucleotide Sequencing of Glutamate Decarboxylase Gene Isoform 65 from Human Brain
by: Abolghasem Esmaeili, et al.
Published: (2015-04-01)

Anti-glutamic Acid Decarboxylase Antibody-associated Cerebellar Ataxia: A Case Report
by: Miray Atacan Yaşgüçlükal, et al.
Published: (2021-03-01)

SdiA Improves the Acid Tolerance of E. coli by Regulating GadW and GadY Expression
by: Xingyan Ma, et al.
Published: (2020-06-01)

Latent autoimmune diabetes of adults (LADA): The informative value of autoantibodies
by: Yu V Silko, et al.
Published: (2016-10-01)

Factors associated with increased irisin levels in the type 1 diabetes mellitus
by: Ates I., et al.
Published: (2017-01-01)

Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
by: Shigetaka Sugihara, et al.
Published: (2020-05-01)

Characterization of three glutamate decarboxylases from Bacillus spp. for efficient γ-aminobutyric acid production
by: Lei Sun, et al.
Published: (2021-08-01)

Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01)

A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody
by: Chandra Mohan Sharma, et al.
Published: (2016-01-01)

Effects of Jobelyn® on Isoniazid-Induced Seizures, Biomarkers of Oxidative Stress and Glutamate Decarboxylase Activity in Mice
by: Stephen Asehinde, et al.
Published: (2018-11-01)

Identification of two CiGADs from Caragana intermedia and their transcriptional responses to abiotic stresses and exogenous abscisic acid
by: Jing Ji, et al.
Published: (2017-06-01)

Analysis on clinical and electrophysiological characteristics of 11 patients with stiff-person syndrome
by: Xin-jing ZHONG, et al.
Published: (2019-06-01)